NCT04352868

Brief Summary

This study will evaluate the ability of toric multifocal contact lens to reduce the change of myopia progression in children (aged 8-12) with myopic astigmatism.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 20, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

November 9, 2020

Status Verified

November 1, 2020

Enrollment Period

1 year

First QC Date

April 15, 2020

Last Update Submit

November 5, 2020

Conditions

Keywords

MyopiaMultifocal contact lensRefractive errorMyopia treatmentMyopia controlMyopia management

Outcome Measures

Primary Outcomes (2)

  • Refractive error progression

    Refractive error measured by cycloplegic autorefraction in both eyes, will be measured at baseline and at one year to assess the difference in spherical component of the refractive error between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)

    1 years

  • Axial length

    Change in axial length as measured by non-contact axial length both eyes, will be measured at baseline and at one year to assess the difference in change in axial length between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)

    1 years

Study Arms (2)

Toric soft contact lens

ACTIVE COMPARATOR

Toric soft contact lens

Device: Intelliwave toric, soft contact lens

Multifocal toric soft contact lens

EXPERIMENTAL

A multifocal toric soft contact lens with a +2.00 D add.

Device: Intelliwave multifocal, toric, soft contact lens

Interventions

This is a quarterly disposable, multifocal, toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

Multifocal toric soft contact lens

This is a quarterly disposable toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

Toric soft contact lens

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • to 12 years, inclusive, at baseline examination
  • to -6.00 D, inclusive, spherical component, cycloplegic autorefraction
  • ≥0.75 DC, cycloplegic autorefraction
  • logMAR or better best-corrected visual acuity in each eye

You may not qualify if:

  • Eye disease or refractive error conditions (e.g., keratoconus, retinal abnormalities, retinopathy of prematurity, etc.)
  • Ocular surgery, severe ocular trauma, active ocular infection or inflammation
  • Subjects with a condition or in a situation, which in the examiner's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive ErrorsMyopia

Interventions

Contact Lenses, Hydrophilic

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Contact LensesLensesOptical DevicesEquipment and Supplies

Study Officials

  • Andrew D Pucker, OD, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 15, 2020

First Posted

April 20, 2020

Study Start

September 1, 2020

Primary Completion

September 1, 2021

Study Completion

September 1, 2022

Last Updated

November 9, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual subject data.